193 related articles for article (PubMed ID: 28624786)
1. High expression of GPR116 indicates poor survival outcome and promotes tumor progression in colorectal carcinoma.
Yang L; Lin XL; Liang W; Fu SW; Lin WF; Tian XQ; Gao YJ; Chen HY; Dai J; Ge ZZ
Oncotarget; 2017 Jul; 8(29):47943-47956. PubMed ID: 28624786
[TBL] [Abstract][Full Text] [Related]
2. Overexpression of NOX4 predicts poor prognosis and promotes tumor progression in human colorectal cancer.
Lin XL; Yang L; Fu SW; Lin WF; Gao YJ; Chen HY; Ge ZZ
Oncotarget; 2017 May; 8(20):33586-33600. PubMed ID: 28422720
[TBL] [Abstract][Full Text] [Related]
3. MiR-511-5p functions as a tumor suppressor and a predictive of prognosis in colorectal cancer by directly targeting GPR116.
Wang C; Fan HQ; Zhang YW
Eur Rev Med Pharmacol Sci; 2019 Jul; 23(14):6119-6130. PubMed ID: 31364112
[TBL] [Abstract][Full Text] [Related]
4. GPR56 promotes proliferation of colorectal cancer cells and enhances metastasis via epithelial‑mesenchymal transition through PI3K/AKT signaling activation.
Ji B; Feng Y; Sun Y; Ji D; Qian W; Zhang Z; Wang Q; Zhang Y; Zhang C; Sun Y
Oncol Rep; 2018 Oct; 40(4):1885-1896. PubMed ID: 30066935
[TBL] [Abstract][Full Text] [Related]
5. CCL20 and CXCL8 synergize to promote progression and poor survival outcome in patients with colorectal cancer by collaborative induction of the epithelial-mesenchymal transition.
Cheng XS; Li YF; Tan J; Sun B; Xiao YC; Fang XB; Zhang XF; Li Q; Dong JH; Li M; Qian HH; Yin ZF; Yang ZB
Cancer Lett; 2014 Jun; 348(1-2):77-87. PubMed ID: 24657657
[TBL] [Abstract][Full Text] [Related]
6. High expression of PFTK1 in cancer cells predicts poor prognosis in colorectal cancer.
Mao Y; Jia Y; Zhu H; Wang W; Jin Q; Huang F; Zhang S; Li X
Mol Med Rep; 2017 Jul; 16(1):224-230. PubMed ID: 28498444
[TBL] [Abstract][Full Text] [Related]
7. GPR116 overexpression correlates with poor prognosis in gastric cancer.
Zheng T; Sun M; Liu L; Lan Y; Wang L; Lin F
Medicine (Baltimore); 2021 Dec; 100(48):e28059. PubMed ID: 35049225
[TBL] [Abstract][Full Text] [Related]
8. The overexpression of AUF1 in colorectal cancer predicts a poor prognosis and promotes cancer progression by activating ERK and AKT pathways.
Tian XY; Li J; Liu TH; Li DN; Wang JJ; Zhang H; Deng ZL; Chen FJ; Cai JP
Cancer Med; 2020 Nov; 9(22):8612-8623. PubMed ID: 33016643
[TBL] [Abstract][Full Text] [Related]
9. GPR48, a poor prognostic factor, promotes tumor metastasis and activates β-catenin/TCF signaling in colorectal cancer.
Wu J; Xie N; Xie K; Zeng J; Cheng L; Lei Y; Liu Y; Song L; Dong D; Chen Y; Zeng R; Nice EC; Huang C; Wei Y
Carcinogenesis; 2013 Dec; 34(12):2861-9. PubMed ID: 23803691
[TBL] [Abstract][Full Text] [Related]
10. STC2 promotes the epithelial-mesenchymal transition of colorectal cancer cells through AKT-ERK signaling pathways.
Chen B; Zeng X; He Y; Wang X; Liang Z; Liu J; Zhang P; Zhu H; Xu N; Liang S
Oncotarget; 2016 Nov; 7(44):71400-71416. PubMed ID: 27662663
[TBL] [Abstract][Full Text] [Related]
11. High expression of protein phosphatase 4 is associated with the aggressive malignant behavior of colorectal carcinoma.
Li X; Liang L; Huang L; Ma X; Li D; Cai S
Mol Cancer; 2015 Apr; 14():95. PubMed ID: 25927939
[TBL] [Abstract][Full Text] [Related]
12. GPR116, an adhesion G-protein-coupled receptor, promotes breast cancer metastasis via the Gαq-p63RhoGEF-Rho GTPase pathway.
Tang X; Jin R; Qu G; Wang X; Li Z; Yuan Z; Zhao C; Siwko S; Shi T; Wang P; Xiao J; Liu M; Luo J
Cancer Res; 2013 Oct; 73(20):6206-18. PubMed ID: 24008316
[TBL] [Abstract][Full Text] [Related]
13. Association of DCBLD2 upregulation with tumor progression and poor survival in colorectal cancer.
He J; Huang H; Du Y; Peng D; Zhou Y; Li Y; Wang H; Zhou Y; Nie Y
Cell Oncol (Dordr); 2020 Jun; 43(3):409-420. PubMed ID: 32166582
[TBL] [Abstract][Full Text] [Related]
14. Downregulation of Lgr6 inhibits proliferation and invasion and increases apoptosis in human colorectal cancer.
Wang F; Dai CQ; Zhang LR; Bing C; Qin J; Liu YF
Int J Mol Med; 2018 Jul; 42(1):625-632. PubMed ID: 29693156
[TBL] [Abstract][Full Text] [Related]
15. Reduced RCE1 expression predicts poor prognosis of colorectal carcinoma.
Shi B; Zhou X; He L; Liang M; Luo Y; Jiang P
BMC Cancer; 2017 Jun; 17(1):414. PubMed ID: 28615075
[TBL] [Abstract][Full Text] [Related]
16. Relationships among
Wan XB; Wang AQ; Cao J; Dong ZC; Li N; Yang S; Sun MM; Li Z; Luo SX
World J Gastroenterol; 2019 Feb; 25(7):808-823. PubMed ID: 30809081
[TBL] [Abstract][Full Text] [Related]
17. Calcium-Activated Chloride Channel A4 (CLCA4) Plays Inhibitory Roles in Invasion and Migration Through Suppressing Epithelial-Mesenchymal Transition via PI3K/AKT Signaling in Colorectal Cancer.
Chen H; Liu Y; Jiang CJ; Chen YM; Li H; Liu QA
Med Sci Monit; 2019 Jun; 25():4176-4185. PubMed ID: 31164625
[TBL] [Abstract][Full Text] [Related]
18. Long non-coding RNA HOXD-AS1 promotes tumor progression and predicts poor prognosis in colorectal cancer.
Li X; Zhao X; Yang B; Li Y; Liu T; Pang L; Fan Z; Ma W; Liu Z; Li Z
Int J Oncol; 2018 Jul; 53(1):21-32. PubMed ID: 29749477
[TBL] [Abstract][Full Text] [Related]
19. Identification and characterization of ANO9 in stage II and III colorectal carcinoma.
Li C; Cai S; Wang X; Jiang Z
Oncotarget; 2015 Oct; 6(30):29324-34. PubMed ID: 26317553
[TBL] [Abstract][Full Text] [Related]
20. LncRNA CHRF-induced miR-489 loss promotes metastasis of colorectal cancer via TWIST1/EMT signaling pathway.
Tao Y; Han T; Zhang T; Ma C; Sun C
Oncotarget; 2017 May; 8(22):36410-36422. PubMed ID: 28430582
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
